Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Mitake Food Manufacturing Co., Ltd. Launches Karaage Fried Chicken Flour Made from Rice in the .
Mitake Food Manufacturing Co., Ltd.February 8, 2021 GMT
Toda City, Feb. 08, 2021 (GLOBE NEWSWIRE) - The food manufacturer has announced the launch of one of its new products, Karaage Fried Chicken Flour, made from Rice to the United States of America from January 1st, 2021.
As a food company with more than 60 years of industry experience and operation in the Japanese landscape, Mitake is endowed with rich food culture. It is ready to introduce healthy food culture to the United States of America through its products.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Exelixis Announces Positive Findings at ASCO GU for CABOMETYX® (cabozantinib) in Patients with Brain Metastases from Renal Cell Carcinoma
February 8, 2021 GMT
ALAMEDA, Calif. (BUSINESS WIRE) Feb 8, 2021
Exelixis, Inc. (NASDAQ: EXEL) today announced results from a retrospective analysis evaluating CABOMETYX ® (cabozantinib) activity in brain metastases in patients with renal cell carcinoma (RCC). The findings will be presented as part of the Poster Session: Renal Cell Cancer at the 2021 American Society of Clinical Oncology’s Genitourinary Cancers Symposium (ASCO GU), which is being held virtually, February 11-13, 2021. All posters will be available on demand beginning at 5:00 a.m. PT on Thursday, February 11.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Ohio National closes 2020 with increased capital; total adjusted capital climbs to record $1.2 .
Ohio National Financial ServicesFebruary 8, 2021 GMT
CINCINNATI, Feb. 08, 2021 (GLOBE NEWSWIRE) Ohio National Financial Services, Inc. today announced a 5.9% increase in statutory total adjusted capital and an 8.4% increase in GAAP equity (including accumulated other comprehensive income, or AOCI) reaching $1.2 billion and $2.8 billion, respectively, while assets under management grew by 1.8%, on an enterprise basis.
During this unprecedented and challenging year, marked by a global pandemic, economic downturn, market volatility and continued low interest rates, Ohio National continued to serve policyholders by paying more than $1.4 billion in benefits1 and continuing to pay dividends to eligible policyholders for the 97th consecutive year2.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
FDA Clears IND Application for Passage Bio’s Gene Therapy Candidate PBKR03 for Treatment of .
Passage BioFebruary 8, 2021 GMT
- Phase 1/2 trial expected to commence in first half of 2021
- Company has three INDs cleared for rare monogenic CNS disorders
PHILADELPHIA, Feb. 08, 2021 (GLOBE NEWSWIRE) Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformative therapies for rare monogenic central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for PBKR03, an adeno-associated virus (AAV)-delivery gene therapy being studied for the treatment of early infantile Krabbe disease (Globoid Cell Leukodystrophy). Currently, there are no approved disease-modifying therapies available for Krabbe disease, a rare lysosomal storage disease that most often